Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB) is a peer-reviewed medical journal published on behalf of the American Heart Association by Lippincott Williams & Wilkins, an imprint of Wolters Kluwer. It covers basic and clinical research related to vascular biology, pathophysiology and complications of atherosclerosis, and thrombotic mechanisms in blood vessels.
The journal was established in 1981 as Arteriosclerosis (ISSN 0276-5047), which was published bimonthly. From 1991 to 1994 it was published monthly under the title Arteriosclerosis and Thrombosis: A Journal of Vascular Biology (ISSN 1049-8834).
According to the Journal Citation Reports, the journal has a 2020 impact factor of 8.311, ranking it 8th in the category "Hematology" and 5th in the category "Peripheral Vascular Disease". Alan Daugherty has been the editor-in-chief since 2012.
Arteriosclerosis
Continued as: Arteriosclerosis and Thrombosis
Scopus coverage years: from 1981 to 1990(coverage discontinued in Scopus)
Publisher: American Heart Association
ISSN: 0276-5047
Subject area:
Medicine: Cardiology and Cardiovascular Medicine
Source type: Journal